Have a personal or library account? Click to login
Clinical significance of serum HMGB1 in COPD and correlation with severity of airflow restriction and immune function Cover

Clinical significance of serum HMGB1 in COPD and correlation with severity of airflow restriction and immune function

Revista Romana de Medicina de Laborator
Volume 30 (2022): Issue 2 (April 2022)
By: Weiguo Xu,  Junhua Wu,  Yong Feng,  Jing Zhu and  Rong Cui  
Open Access
|May 2022

Authors

Weiguo Xu

xuweiguomch@mail.ru

Department of Respiratory Medicine, Mianyang Central Hospital, China

Junhua Wu

Department of Respiratory Medicine, Mianyang Central Hospital, China

Yong Feng

Department of Traditional Chinese Medicine, Mianyang Central Hospital, China

Jing Zhu

Department of Respiratory Medicine, Mianyang Central Hospital, China

Rong Cui

Department of Ultrasound Medicine, Mianyang Central Hospital, China
DOI: https://doi.org/10.2478/rrlm-2022-0013 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624
Journal RSS Feed
Language: English
Page range: 173 - 181
Submitted on: Nov 23, 2021
|
Accepted on: Feb 24, 2022
|
Published on: May 9, 2022
Published by: Romanian Association of Laboratory Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
smoking,
chronic obstructive pulmonary disease,
airflow restriction,
immune function,
correlation
Related subjects:
Life sciences,
Molecular biology,
Biochemistry,
Human biology,
Microbiology and virology

© 2022 Weiguo Xu, Junhua Wu, Yong Feng, Jing Zhu, Rong Cui, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 30 (2022): Issue 2 (April 2022)Next article